Received Feb 26, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| HEPA | HEP A (HAVRIX) | GLAXOSMITHKLINE BIOLOGICALS | UNK | — | — |
receive a 1 mL dose of Havrix instead of the 0.5 mL dose..; This non-serious case was reported by a pharmacist via call center representative and described the occurrence of overdose in a 12-month-old patient who received HAV (Havrix) for prophylaxis. Concurrent medical conditions included idiopathic thrombocytopenia. On 19-FEB-2025, the patient received Havrix. On an unknown date, an unknown time after receiving Havrix, the patient experienced overdose (Verbatim: receive a 1 mL dose of Havrix instead of the 0.5 mL dose..). The outcome of the overdose was not applicable. This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences. Additional Information: GSK Receipt Date: 24-FEB-2025 On 24/Feb/2025, a pharmacist called to inform about a vaccine error about Havrix, they had a 12-month-old patient received a 1 mL dose of Havrix instead of the 0.5 mL dose, which led to overdose. Also, reporter mentioned that the patient had idiopathic thrombocytopenia as a preexisting condition.
Idiopathic thrombocytopenia